Patent Assignment
Reel/Frame 012036/0167
Change of Name
Recorded: 2001-10-04
Pages: 6
Assignor
RHONE-POULENC RORER PHARMACEUTICALS INC.
Executed: 1999-12-15
Assignee
AVENTIS PHARMACEUTICALS PRODUCTS INC.
P.O. BOX 6800, MAIL STIP EMC-G1, RT. 202-206, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(17)
Recombinant Dna Vector Encoding Human Endothelial Cell Growth Factor
Patent:
4,868,113 →
Application:
06/835,594 →
Pharmacological Dissolution Method and Apparatus
Patent:
4,856,909 →
Application:
06/877,146 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,132 →
Application:
07/116,420 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,133 →
Application:
07/116,428 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,130 →
Application:
07/116,597 →
Quinolinyl Ether or Thioether Tetrazoles as Agents for the Treatment of Hypersensitive Ailments
Patent:
4,874,769 →
Application:
07/124,800 →
Dibenzofurancarboxamides and Their Pharmaceutical Compositions and Methods
Patent:
4,863,921 →
Application:
07/186,824 →
Method for the Preparation of a Theophylline Sustained Release Pharmaceutical Composition and the Composition Prepared Thereby
Patent:
5,026,709 →
Application:
07/203,435 →
Product-Dispensing Method and Apparatus
Patent:
4,876,891 →
Application:
07/203,566 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,131 →
Application:
07/209,428 →
Intranasal Calcitonin Formulations
Patent:
5,026,825 →
Application:
07/242,000 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent:
5,051,427 →
Application:
07/449,957 →
Quinoline Derivatives and Their Use as Antagonists of Leukotriene D4
Patent:
5,059,610 →
Application:
07/477,896 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent:
5,028,615 →
Application:
07/499,513 →
Binding Theophylline to Ion Exchange Resins
Patent:
5,162,110 →
Application:
07/629,833 →
Product-Dispensing Method and Apparatus
Patent:
5,125,466 →
Application:
07/649,304 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent:
5,166,210 →
Application:
07/724,745 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Oct 8, 2001
From: RORER PHARMACEUTICAL CORPORATION
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 012036/0745 →
Assignment of Assignor's Interest
Jan 8, 2002
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: GENCELL, INC.
Reel/Frame 012280/0901 →
Change of Name
May 18, 2006
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 017636/0360 →